POS-247 ROXADUSTAT FOR THE TREATMENT OF ANEMIA IN CHRONIC KIDNEY DISEASE (CKD) PATIENTS NOT ON DIALYSIS (NDD): A PHASE 3, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY

POS-247 ROXADUSTAT FOR THE TREATMENT OF ANEMIA IN CHRONIC KIDNEY DISEASE (CKD) PATIENTS NOT ON DIALYSIS (NDD): A PHASE 3, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY

Bibliographic Details
Main Authors:	J. BARRATT, B. Andric, A. Tataradze, M. Schömig, M. Reusch, U. Valluri, C. Mariat
Format:	Article
Language:	English
Published:	Elsevier 2021-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024921004083

Similar Items

POS-244 A PHASE 3, MULTICENTER, RANDOMIZED, OPEN-LABEL, ACTIVE COMPARATOR CONVERSION STUDY OF ROXADUSTAT IN NON–DIALYSIS-DEPENDENT (NDD) PATIENTS WITH ANEMIA IN CHRONIC KIDNEY DISEASE (CKD)
by: T. Akizawa, et al.
Published: (2021-04-01)

POS-256 ROXADUSTAT INCREASES HEMOGLOBIN IN ANEMIC NON-DIALYSIS-DEPENDENT (NDD) AND DIALYSIS-DEPENDENT (DD) CHRONIC KIDNEY DISEASE (CKD) PATIENTS INDEPENDENT OF INFLAMMATION
by: C. Pollock, et al.
Published: (2021-04-01)

POS-283 HEMOGLOBIN (HB) CORRECTION WITH ROXADUSTAT IS ASSOCIATED WITH IMPROVED IRON HOMEOSTASIS IN PATIENTS WITH NON-DIALYSIS-DEPENDENT (NDD) AND DIALYSIS-DEPENDENT (DD) CHRONIC KIDNEY DISEASE (CKD)
by: P. Pergola, et al.
Published: (2021-04-01)

POS-282 ROXADUSTAT TREATMENT RESULTS IN CONSISTENT IMPROVEMENTS IN HEMOGLOBIN (HB) VERSUS PLACEBO: AN ANALYSIS OF THREE MULTINATIONAL RCTS IN PATIENTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE (NDD-CKD)
by: R. Pecoits Filho MD, et al.
Published: (2021-04-01)

Association of obesity with mortality in patients with various stages of non-dialysis dependent CKD (NDD-CKD)
by: Csaba P Kovesdy, et al.
Published: (2012-06-01)

POS-292 OPHTHALMOLOGICAL EFFECTS OF ROXADUSTAT IN THE TREATMENT OF ANEMIA IN DIALYSIS-DEPENDENT AND NON–DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE PATIENTS: FINDINGS FROM TWO PHASE 3 STUDIES
by: Y. Sepah, et al.
Published: (2021-04-01)

POS-321 TRANSLATING THE FINDINGS OF THE ROXADUSTAT NDD GLOBAL PHASE 3 PROGRAM INTO COST OFFSETS FROM A CANADIAN HEALTHCARE PERSPECTIVE
by: J. Schneider, et al.
Published: (2021-04-01)

Effects of Roxadustat on the Anemia and Iron Metabolism of Patients Undergoing Peritoneal Dialysis
by: Keiji Hirai, et al.
Published: (2021-07-01)

A Novel Choice to Correct Inflammation-Induced Anemia in CKD: Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat
by: Zhipeng Yan, et al.
Published: (2020-08-01)

POS-284 CARDIOVASCULAR OUTCOMES AND EXPLORATORY ANALYSES BY ACHIEVED HB LEVELS IN POOLED PHASE 3 TRIALS OF ROXADUSTAT IN DIALYSIS-DEPENDENT PATIENTS WITH ANEMIA OF CHRONIC KIDNEY DISEASE
by: R. Provenzano, et al.
Published: (2021-04-01)

Roxadustat in treating anemia in dialysis patients (ROAD): protocol and rationale of a multicenter prospective observational cohort study
by: Yaling Zhang, et al.
Published: (2021-01-01)

POS-258 CARDIOVASCULAR OUTCOMES AND EXPLORATORY ANALYSES BY ACHIEVED HB LEVELS IN THE POOLED PHASE 3 ROXADUSTAT STUDIES OF NON-DIALYSIS-DEPENDENT PATIENTS WITH ANEMIA OF CHRONIC KIDNEY DISEASE
by: S. Fishbane, et al.
Published: (2021-04-01)

Whether Prolyl Hydroxylase Blocker—Roxadustat—in the Treatment of Anemia in Patients with Chronic Kidney Disease Is the Future?
by: Władysław Grzeszczak, et al.
Published: (2021-02-01)

POS-320 INSIDE ANEMIA OF CKD: QUANTIFYING THE EPIDEMIOLOGICAL BURDEN OF ANEMIA OF CKD IN CANADA VIA MICROSIMULATION MODELLING
by: J.J. GARCIA SANCHEZ, et al.
Published: (2021-04-01)

Safety and Efficacy of Roxadustat for Anemia in Patients With Chronic Kidney Disease: A Meta-Analysis and Trial Sequential Analysis
by: Chao Liu, et al.
Published: (2021-08-01)

ASSOCIATION BETWEEN ANEMIA AND BONE PROFILE IN NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE ANEMIA AND BONE PROFILE IN CKD
by: Shamsa Kanwal, et al.
Published: (2021-08-01)

Suppression of thyrotropin secretion during roxadustat treatment for renal anemia in a patient undergoing hemodialysis
by: Mitsuru Ichii, et al.
Published: (2021-03-01)

Effects of Erythropoietin-Stimulating Agents on Blood Pressure in Patients with Non-Dialysis CKD and Renal Anemia
by: Kohji Ohki, et al.
Published: (2020-06-01)

POS-270 STRUCTURAL AND FUNCTIONAL CARDIOVASCULAR DISEASE IN CHILDREN AND YOUNG ADULTS WITH CKD AND ON DIALYSIS
by: A. LALAYIANNIS, et al.
Published: (2021-04-01)

Trends in anemia care in non-dialysis-dependent chronic kidney disease (CKD) patients in the United States (2006–2015)
by: Haesuk Park, et al.
Published: (2018-11-01)

Treatment of depression in chronic kidney disease (CKD) patients on dialysis
by: Nawfel Abdulameer, et al.
Published: (2016-09-01)

Statin and anemia in chronic kidney disease (CKD): an experimental study
by: Cahyawati P N, et al.
Published: (2018-01-01)

The Influence of Inflammation on Anemia in CKD Patients
by: Anna Gluba-Brzózka, et al.
Published: (2020-01-01)

Homoarginine and mortality in pre-dialysis chronic kidney disease (CKD) patients.
by: Pietro Ravani, et al.
Published: (2013-01-01)

Positive and Negative Aspects of Sodium Intake in Dialysis and Non-Dialysis CKD Patients
by: Yasuyuki Nagasawa
Published: (2021-03-01)

Anemia and Iron Deficiency in Children with Chronic Kidney Disease (CKD): Data from the Know-Ped CKD Study
by: Keum Hwa Lee, et al.
Published: (2019-01-01)

Pulse Coupled Neural Network based Near-Duplicate Detection of Images (PCNN - NDD)
by: THYAGHARAJAN, K. K., et al.
Published: (2018-08-01)

Diagnosis Patterns of CKD and Anemia in the Japanese Population
by: Tomomi Kimura, et al.
Published: (2020-05-01)

Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial.
by: Carlo A Gaillard, et al.
Published: (2016-01-01)

Definitions and Operationalization of Mental Health Problems, Wellbeing and Participation Constructs in Children with NDD: Distinctions and Clarifications
by: Mats Granlund, et al.
Published: (2021-02-01)

Ndd1 turnover by SCF(Grr1) is inhibited by the DNA damage checkpoint in Saccharomyces cerevisiae.
by: Ellen R Edenberg, et al.
Published: (2015-04-01)

MDRD or CKD-EPI study equations for estimating prevalence of stage 3 CKD in epidemiological studies: which difference? Is this difference relevant?
by: Maillard Nicolas, et al.
Published: (2010-06-01)

Obesity and Other Nutrition Related Abnormalities in Pre-Dialysis Chronic Kidney Disease (CKD) Participants
by: Zarina Ebrahim, et al.
Published: (2020-11-01)

Clinical and Healthcare Utilization Outcomes of Parathyroidectomy in CKD and Dialysis Patients
by: Scott A. Jones, et al.
Published: (2020-07-01)

THE PARTICULARITIES OF ABPM PARAMETERS IN HYPERTENSIVE PATIENTS WITH NON-DIALYSIS CKD
by: Alexandru Minca, et al.
Published: (2017-12-01)

Factors Influencing of Peritoneal Dialysis Modality Selection in the CKD Patients
by: Jia-Huey Liang, et al.
Published: (2008)

Clinical Significance of Phase Angle in Non-Dialysis CKD Stage 5 and Peritoneal Dialysis Patients
by: Byoung-Geun Han, et al.
Published: (2018-09-01)

Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial
by: Shubhadeep D. Sinha, et al.
Published: (2019-03-01)

Roxadustat attenuates hyperoxia-induced lung injury by upregulating proangiogenic factors in newborn mice
by: Liang-Ti Huang, et al.
Published: (2021-07-01)

2233 COLTURE SU CONGIUNTIVITI DI n.d.d.: INDAGINE EPIDEMIOLOGICA IN 6 ANNI DI OSSERVAZIONE.
by: F. Giardini, et al.
Published: (2007-09-01)